EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Infertility, IL-17, IL-33 and Microbiome Cross-Talk: The Extended ARIA-MeDALL Hypothesis

Samir Hamamah, Fatima Barry iD, Sarah Vannier, Tal Anahory, Tari Haahtela, Josep M Antó, Charles Chapron, Jean-Marc Ayoubi, Wienczyslawa Czarlewski, Jean Bousquet

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms252211981 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Samir Hamamah und 9 weiteren Autor:innen. Beteiligte Einrichtung: Biologie de la Reproduction, Hôpital Arnaud de Villeneuve, 34295 Montpellier, France. Hauptthemen laut MEDLINE: Interleukin-33, Interleukin-17, Dysbiosis, Endometriosis. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 90 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Infertility, defined as the inability to obtain pregnancy after 12 months of regular unprotected sexual intercourse, has increased in prevalence over the past decades, similarly to chronic, allergic, autoimmune, or neurodegenerative diseases. A recent ARIA-MeDALL hypothesis has proposed that all these diseases are linked to dysbiosis and to some cytokines such as interleukin 17 (IL-17) and interleukin 33 (IL-33). Our paper suggests that endometriosis, a leading cause of infertility, is linked to endometrial dysbiosis and two key cytokines, IL-17 and IL-33, which interact with intestinal dysbiosis. Intestinal dysbiosis contributes to elevated estrogen levels, a primary factor in endometriosis. Estrogens strongly activate IL-17 and IL-33, supporting the existence of a gut–endometrial axis as a significant contributor to infertility.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Interleukin-33Interleukin-17DysbiosisEndometriosisHumansFemaleGastrointestinal MicrobiomeMicrobiotaInfertilityEndometriumEstrogensAnimals

Stichwörter der Autor:innen

IL-17IL-33dysbiosisendometriosisestrogensinfertility

Substanzen

Interleukin-33Interleukin-17IL33 protein, humanEstrogens

Autor:innen und Institutionen

  • Biologie de la Reproduction, Hôpital Arnaud de Villeneuve, 34295 Montpellier, France.
  • INSERM DEFE, Université de Montpellier, 34090 Montpellier, France.
  • Gynécologie Médicale, Hôpital Arnaud de Villeneuve, 34295 Montpellier, France.
  • Skin and Allergy Hospital, Helsinki University Hospital, 00250 Helsinki, Finland.
  • ISGlobal, Barcelona Institute for Global Health, 08036 Barcelona, Spain.
  • IMIM (Hospital del Mar Medical Research Institute), 08003 Barcelona, Spain.

ORCID-Profile: Fatima Barry

Zitieren

APA

Hamamah, S., Barry, F., Vannier, S., Anahory, T., Haahtela, T., Antó, J. M., Chapron, C., Ayoubi, J. M., Czarlewski, W., & Bousquet, J. (2024). Infertility, IL-17, IL-33 and Microbiome Cross-Talk: The Extended ARIA-MeDALL Hypothesis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252211981

Vancouver

Hamamah S, Barry F, Vannier S, Anahory T, Haahtela T, Antó JM, et al. Infertility, IL-17, IL-33 and Microbiome Cross-Talk: The Extended ARIA-MeDALL Hypothesis. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252211981

BibTeX
@article{Hamamah2024,
  author = {Hamamah, Samir and Barry, Fatima and Vannier, Sarah and Anahory, Tal and Haahtela, Tari and Antó, Josep M and Chapron, Charles and Ayoubi, Jean-Marc and Czarlewski, Wienczyslawa and Bousquet, Jean},
  title = {Infertility, IL-17, IL-33 and Microbiome Cross-Talk: The Extended ARIA-MeDALL Hypothesis},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms252211981}
}
Kostenlos starten →